ArticleBJR open2019

Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapy.

Dominic Carlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.